欢迎访问西亚试剂!
西亚试剂banner
西亚试剂banner
西亚试剂banner

当前位置:首页 > 新闻中心

西亚试剂:Identification of key regulatory pathways of myeloid differ

发布时间:2026-01-01

Identification of key regulatory pathways of myeloid differentiation using an mESC-based karyotypically normal cell model

Dong Li1, Hong Yang1, Hong Nan1, Peng Liu2, Sulei Pang2,Qian Zhao3, Rotem Karni4, Mark P. Kamps5, Yuanfu Xu2, Jiaxi Zhou2,Therese Wiedmer6, Peter J. Sims6, and Fei Wang1,*

Understanding the process of myeloid differentiation offers important insights into both normal and abnormal developmental processes, but is limited by the dearth of experimental models. Here we show that myeloid progenitors can be derived from embryonic stem cells (ESCs), immortalized, and applied to the study of the mechanisms underlying myeloid differentiation. The ESC-derived myeloid progenitors, when immortalized with estrogen-regulated Hoxb8 protein (Hoxb8-ER), demonstrate normal karyotyping, are genetically tractable, and can be differentiated into functional neutrophils. By using this model, we identified Mammalian Target of Rapamycin Complex 1 (mTORC1) as a critical regulator of myeloid differentiation. Together, our studies led to a convenient, karyotypically normal and genetically manipulatable cellular system, which can be used to shed new light on the mechanisms for myeloid differentiation.

 

上一篇:西亚试剂:武汉大学发现一种新的水稻细胞质源
下一篇:西亚试剂:美国发现脂肪储存重要基因
版权所有:山东西亚化学有限公司

鲁ICP备20015914号-4